Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.
Telo Genomics has raised $1.2M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in January 2026.
Telo Genomics is headquartered in Toronto, Canada.
Telo Genomics, a biotech company that offers telomere platform for biopsies and related technologies in oncology and neurological diseases.
Telo Genomics is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Telo Genomics — Funding & Investors." VCBacked, January 19, 2026, https://www.vcbacked.co/company/telo-genomics. Accessed August 15, 2026.
VCBacked. (2026). Telo Genomics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/telo-genomics
{{cite web |title=Telo Genomics — Funding & Investors |url=https://www.vcbacked.co/company/telo-genomics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated